Private Capital Group’s Akcea Therapeutics Inc AKCA Stock Holding History
Bought
Maintained
Sold
Private Capital Group's AKCA Position: Q4 2020 in Review
Private Capital Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 65 shares — an estimated $1K sold.
Private Capital Group first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.
- Private Capital Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
- Private Capital Group sold 65 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1K.
- Private Capital Group first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
- Private Capital Group's Akcea Therapeutics Inc position peaked at $1K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.
Based on Private Capital Group's 13F filing for Q4 2020, filed 26 Jan 2021.